Somatropin (HGH) vs Tesamorelin
Updated 11 sources
Key differences
- 1Tesamorelin is a GHRH analogue approved only for HIV-associated lipodystrophy; somatropin is approved for GH deficiency, growth disorders and HIV wasting.
- 2Both are prescription drugs, but only hGH distribution for unapproved uses is a specific federal crime.
Side by side
Facts from each record, in the same words as their own pages.
| Somatropin (HGH) | Tesamorelin | |
|---|---|---|
| Category |
|
|
| Evidence |
|
|
| FDA status |
|
|
| WADA |
|
|
| Half-life |
|
|
| Routes |
|
|
| Forms |
| Not reported |
| Reported doses |
|
|
| Most cited frequency |
|
|
| Vial sizes |
|
|
| Mixed vial keeps |
|
|
| Protocols on file |
|
|
Doses shown are what sources report, labelled by origin. Not medical advice.
Read each in full
Sources
11 sources, each checked by date. Record updated Oct 24, 2026. Numbers are restated in our own words and labelled by where they came from.
Clinical study1
- Performance-enhancing peptides modulating GH-IGF1 axis (Dominikowski 2026)PMC · checked Oct 23, 2026
Regulatory9
- Genotropin (somatropin) prescribing informationDailyMed · checked Oct 24, 2026
- Humatrope (somatropin) prescribing informationDailyMed · checked Oct 24, 2026
- Omnitrope (somatropin) prescribing informationDailyMed · checked Oct 24, 2026
- Egrifta SV labelDailyMed · checked Oct 23, 2026
Competitor guide1
- HGH vs Peptidespeptidesexplorer.com · checked Oct 24, 2026